Stammdaten
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.
Unternehmen & Branche
| Name | BURZYNSKI RESEARCH INSTITUTE INC |
|---|---|
| Ticker | BZYR |
| CIK | 0000724445 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2835 · In Vitro & In Vivo Diagnostic Substances |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 4,2 Mio. USD |
| Beta | 0,42 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-11-30 | 10-Q | 0 | -328,862 | 0.00 | 2,265 | -67,343 |
| 2025-08-31 | 10-Q | 0 | -333,867 | 0.00 | 1,331 | -69,571 |
| 2025-05-31 | 10-Q | 0 | -331,451 | 0.00 | 1,521 | -69,716 |
| 2025-02-28 | 10-K | 0 | -1,386,207 | -0.01 | 847 | -41,637 |
| 2024-11-30 | 10-Q | 0 | -352,239 | 0.00 | 713 | -21,326 |
| 2024-08-31 | 10-Q | 0 | -369,838 | 0.00 | 1,616 | -87,634 |
| 2024-05-31 | 10-Q | 0 | -371,332 | 0.00 | 997 | -127,868 |
| 2024-02-29 | 10-K | 0 | -1,335,431 | -0.01 | 2,310 | -25,123 |
| 2023-11-30 | 10-Q | 0 | -433,015 | 0.00 | 1,013 | -34,834 |
| 2023-08-31 | 10-Q | 0 | -252,104 | 0.00 | 1,797 | -4,476 |
| 2023-05-31 | 10-Q | 0 | -287,405 | 0.00 | 848 | -70,518 |
| 2023-02-28 | 10-K | 0 | -916,292 | -0.01 | 1,934 | -13,727 |
| 2022-11-30 | 10-Q | 0 | -252,639 | 0.00 | 1,792 | -26,628 |
| 2022-08-31 | 10-Q | 0 | -215,918 | 0.00 | 1,666 | -13,638 |
| 2022-05-31 | 10-Q | 0 | -231,737 | 0.00 | 5,466 | -38,680 |
| 2022-02-28 | 10-K | 0 | -0.01 | 4,661 | 1,206 | |
| 2021-11-30 | 10-Q | 0 | 0.00 | 6,739 | 5,350 | |
| 2021-08-31 | 10-Q | 0 | 0.00 | 1,840 | -27,831 | |
| 2021-05-31 | 10-Q | 0 | 0.00 | 2,009 | -61,233 | |
| 2021-02-28 | 10-K | 0 | -0.01 | 956 | -45,843 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.